DYN Competitors & Alternatives
Compare Dyne Therapeutics Inc with similar stocks in the same industry
Biotechnology
DYN
Main Stock$17.37
Tradestie Score
57
Market Cap
$1.78B
Analyst Upside
+119.8%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$29.85
|
$3.09B | - | 62 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$30.89
|
$3.08B | - | 50 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.75
|
$3.03B | - | 56 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$54.17
|
$3.02B | - | 53 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$64.25
|
$3.01B | - | 52 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$23.39
|
$2.89B | - | 51 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$34.15
|
$2.85B | - | 67 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.26
|
$2.56B | 18.1 | 55 | Compare |
More DYN Analysis
Data updated: May 22, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry